{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:03:29Z","timestamp":1788318209276,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00210-025-04189-6","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T03:32:00Z","timestamp":1745551920000},"page":"14273-14289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bioinformatics analysis reveals CTSF suppresses tumor cell malignant phenotype and CD8 +\u2009T cell exhaustion by downregulating Bcl- 2 protein in the microenvironment of bladder cancer"],"prefix":"10.1007","volume":"398","author":[{"given":"Dan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Tie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanhai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoxin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"4189_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115299","volume":"166","author":"M Alipour","year":"2023","unstructured":"Alipour M, Sheikhnejad R, Fouani MH, Bardania H, Hosseinkhani S (2023) DNAi-peptide nanohybrid smart particles target BCL-2 oncogene and induce apoptosis in breast cancer cells. Biomed Pharmacother 166:115299","journal-title":"Biomed Pharmacother"},{"key":"4189_CR2","doi-asserted-by":"crossref","unstructured":"Baessler A, Vignali DAA (2024) T Cell Exhaustion. Annu Rev Immunol 42:179\u2013206","DOI":"10.1146\/annurev-immunol-090222-110914"},{"key":"4189_CR3","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41590-022-01224-z","volume":"23","author":"JA Belk","year":"2022","unstructured":"Belk JA, Daniel B, Satpathy AT (2022) Epigenetic regulation of T cell exhaustion. Nat Immunol 23:848\u2013860","journal-title":"Nat Immunol"},{"key":"4189_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.biochi.2019.05.002","volume":"166","author":"B Breznik","year":"2019","unstructured":"Breznik B, Mitrovi\u0107 A, T TL, Kos J, (2019) Cystatins in cancer progression: more than just cathepsin inhibitors. Biochimie 166:233\u2013250","journal-title":"Biochimie"},{"key":"4189_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","volume":"51","author":"Z Chen","year":"2019","unstructured":"Chen Z, Ji Z, Ngiow SF, Manne S, Cai Z, Huang AC, Johnson J, Staupe RP, Bengsch B, Xu C, Yu S, Kurachi M, Herati RS, Vella LA, Baxter AE, Wu JE, Khan O, Beltra JC, Giles JR, Stelekati E, McLane LM, Lau CW, Yang X, Berger SL, Vahedi G, Ji H, Wherry EJ (2019) TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision. Immunity 51:840-855.e845","journal-title":"Immunity"},{"key":"4189_CR6","doi-asserted-by":"publisher","first-page":"1386517","DOI":"10.3389\/fimmu.2024.1386517","volume":"15","author":"G Corradi","year":"2024","unstructured":"Corradi G, Forte D, Cristiano G, Polimeno A, Ciciarello M, Salvestrini V, Bandini L, Robustelli V, Ottaviani E, Cavo M, Ocadlikova D, Curti A (2024) Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1(+)TIM3(+) exhausted CD8(+) T cells. Front Immunol 15:1386517","journal-title":"Front Immunol"},{"key":"4189_CR7","doi-asserted-by":"publisher","first-page":"1205984","DOI":"10.3389\/fimmu.2023.1205984","volume":"14","author":"I Damei","year":"2023","unstructured":"Damei I, Trickovic T, Mami-Chouaib F, Corgnac S (2023) Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy. Front Immunol 14:1205984","journal-title":"Front Immunol"},{"key":"4189_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.euf.2023.04.011","volume":"9","author":"F Davaro","year":"2023","unstructured":"Davaro F, Jain R, Li R (2023) Immune checkpoint inhibitor toxicity management in non-muscle-invasive bladder cancer: what urologists need to know. Eur Urol Focus 9:579\u2013581","journal-title":"Eur Urol Focus"},{"key":"4189_CR9","doi-asserted-by":"publisher","first-page":"21.e21","DOI":"10.1016\/j.urolonc.2023.09.010","volume":"42","author":"AM Durant","year":"2024","unstructured":"Durant AM, Choudry MM, Madura G, Mi L, Faraj KS, Tyson MD (2024) Bacillus Calmette-Guerin (BCG) therapy is safe and effective in non-muscle invasive bladder cancer (NMIBC) patients with immunomodulating conditions. Urol Oncol 42:21.e21-21.e28","journal-title":"Urol Oncol"},{"key":"4189_CR10","doi-asserted-by":"publisher","unstructured":"Flores-Romero H, Garc\u00eda-S\u00e1ez AJ (2019) The Incomplete Puzzle of the BCL2 Proteins. Cells 8. https:\/\/doi.org\/10.3390\/cells8101176","DOI":"10.3390\/cells8101176"},{"key":"4189_CR11","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1134\/S0006297923070143","volume":"88","author":"AS Frolova","year":"2023","unstructured":"Frolova AS, Tikhomirova NK, Kireev II, Zernii EY, Parodi A, Ivanov KI, Zamyatnin AA Jr (2023) Expression, intracellular localization, and maturation of cysteine cathepsins in renal embryonic and cancer cell lines. Biochemistry (Mosc) 88:1034\u20131044","journal-title":"Biochemistry (Mosc)"},{"key":"4189_CR12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1159\/000443034","volume":"38","author":"MS Guida","year":"2016","unstructured":"Guida MS, El-Aal AA, Kafafy Y, Salama SF, Badr BM, Badr G (2016) Thymoquinone rescues T lymphocytes from gamma irradiation-induced apoptosis and exhaustion by modulating pro-inflammatory cytokine levels and PD-1, Bax, and Bcl-2 signaling. Cell Physiol Biochem 38:786\u2013800","journal-title":"Cell Physiol Biochem"},{"key":"4189_CR13","doi-asserted-by":"crossref","unstructured":"Huang X, Zhang W (2023) Overcoming T cell exhaustion in tumor microenvironment via immune checkpoint modulation with nano-delivery systems for enhanced immunotherapy. Small Methods: e2301326","DOI":"10.1002\/smtd.202301326"},{"key":"4189_CR14","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.3389\/fimmu.2019.02037","volume":"10","author":"T Jako\u0161","year":"2019","unstructured":"Jako\u0161 T, Pi\u0161lar A, Jewett A, Kos J (2019) Cysteine cathepsins in tumor-associated immune cells. Front Immunol 10:2037","journal-title":"Front Immunol"},{"key":"4189_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3727\/096504017X14928634401204","volume":"26","author":"C Ji","year":"2018","unstructured":"Ji C, Zhao Y, Kou YW, Shao H, Guo L, Bao CH, Jiang BC, Chen XY, Dai JW, Tong YX, Yang R, Sun W, Wang Q (2018) Cathepsin F knockdown induces proliferation and inhibits apoptosis in gastric cancer cells. Oncol Res 26:83\u201393","journal-title":"Oncol Res"},{"key":"4189_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, Black PC, Comp\u00e9rat E, Kamat AM, Kiemeney L, Lawrentschuk N, Lerner SP, Meeks JJ, Moch H, Necchi A, Panebianco V, Sridhar SS, Znaor A, Catto JWF, Cumberbatch MG (2023) Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol 84:176\u2013190","journal-title":"Eur Urol"},{"key":"4189_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","volume":"28","author":"D Kaloni","year":"2023","unstructured":"Kaloni D, Diepstraten ST, Strasser A, Kelly GL (2023) BCL-2 protein family: attractive targets for cancer therapy. Apoptosis 28:20\u201338","journal-title":"Apoptosis"},{"key":"4189_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/bph.16141","volume":"181","author":"J Kandhavelu","year":"2024","unstructured":"Kandhavelu J, Subramanian K, Naidoo V, Sebastianelli G, Doan P, Konda Mani S, Yapislar H, Haciosmanoglu E, Arslan L, Ozer S, Thiyagarajan R, Candeias NR, Penny C, Kandhavelu M, Murugesan A (2024) A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2\/BAX and p53 in colon cancer. Br J Pharmacol 181:107\u2013124","journal-title":"Br J Pharmacol"},{"key":"4189_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13075-023-03203-7","volume":"25","author":"K Kielbassa","year":"2023","unstructured":"Kielbassa K, Van der Weele L, Voskuyl AE, de Vries N, Eldering E, Kuijpers TW (2023) Differential expression pattern of Bcl-2 family members in B and T cells in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther 25:225","journal-title":"Arthritis Res Ther"},{"key":"4189_CR20","doi-asserted-by":"publisher","unstructured":"Lan X, Zebley CC, Youngblood B (2023) Cellular and molecular waypoints along the path of T cell exhaustion. Sci Immunol 8: eadg3868. https:\/\/doi.org\/10.1126\/sciimmunol.adg3868","DOI":"10.1126\/sciimmunol.adg3868"},{"key":"4189_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1182\/blood.2020009081","volume":"138","author":"JB Lee","year":"2021","unstructured":"Lee JB, Khan DH, Hurren R, Xu M, Na Y, Kang H, Mirali S, Wang X, Gronda M, Jitkova Y, MacLean N, Arruda A, Alaniz Z, Konopleva MY, Andreeff M, Minden MD, Zhang L, Schimmer AD (2021) Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production. Blood 138:234\u2013245","journal-title":"Blood"},{"key":"4189_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1158\/0008-5472.CAN-23-1448","volume":"84","author":"C Li","year":"2024","unstructured":"Li C, Guo H, Zhai P, Yan M, Liu C, Wang X, Shi C, Li J, Tong T, Zhang Z, Ma H, Zhang J (2024a) Spatial and single-cell transcriptomics reveal a cancer-associated fibroblast subset in HNSCC that restricts infiltration and antitumor activity of CD8+ T cells. Cancer Res 84:258\u2013275","journal-title":"Cancer Res"},{"key":"4189_CR23","doi-asserted-by":"publisher","unstructured":"Li F, Wang Y, Chen D, Du Y (2024b) Nanoparticle-based immunotherapy for reversing T-Cell exhaustion. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/ijms25031396","DOI":"10.3390\/ijms25031396"},{"key":"4189_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105154","volume":"104","author":"WP Lin","year":"2024","unstructured":"Lin WP, Li H, Sun ZJ (2024) T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle. EBioMedicine 104:105154","journal-title":"EBioMedicine"},{"key":"4189_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12943-022-01516-w","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu L, Cheng X, Yang H, Lian S, Jiang Y, Liang J, Chen X, Mo S, Shi Y, Zhao S, Li J, Jiang R, Yang DH, Wu Y (2022) BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion. Mol Cancer 21:59","journal-title":"Mol Cancer"},{"key":"4189_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41419-019-1581-6","volume":"10","author":"X Long","year":"2019","unstructured":"Long X, Xiong W, Zeng X, Qi L, Cai Y, Mo M, Jiang H, Zhu B, Chen Z, Li Y (2019) Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1\/ER\u03b2\/Bcl-2 signalling. Cell Death Dis 10:375","journal-title":"Cell Death Dis"},{"key":"4189_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L (2024) Advances in diagnosis and treatment of bladder cancer. BMJ 384:e076743","journal-title":"BMJ"},{"key":"4189_CR28","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1038\/s41467-021-27210-x","volume":"12","author":"D Lv","year":"2021","unstructured":"Lv D, Pal P, Liu X, Jia Y, Thummuri D, Zhang P, Hu W, Pei J, Zhang Q, Zhou S, Khan S, Zhang X, Hua N, Yang Q, Arango S, Zhang W, Nayak D, Olsen SK, Weintraub ST, Hromas R, Konopleva M, Yuan Y, Zheng G, Zhou D (2021) Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity. Nat Commun 12:6896","journal-title":"Nat Commun"},{"key":"4189_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41585-023-00773-8","volume":"20","author":"M Maas","year":"2023","unstructured":"Maas M, Todenh\u00f6fer T, Black PC (2023) Urine biomarkers in bladder cancer - current status and future perspectives. Nat Rev Urol 20:597\u2013614","journal-title":"Nat Rev Urol"},{"key":"4189_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41419-020-2670-2","volume":"11","author":"D Mamriev","year":"2020","unstructured":"Mamriev D, Abbas R, Klingler FM, Kagan J, Kfir N, Donald A, Weidenfeld K, Sheppard DW, Barkan D, Larisch S (2020) A small-molecule ARTS mimetic promotes apoptosis through degradation of both XIAP and Bcl-2. Cell Death Dis 11:483","journal-title":"Cell Death Dis"},{"key":"4189_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12660","volume":"28","author":"C Mazzotta","year":"2021","unstructured":"Mazzotta C, Marden G, Farina A, Bujor A, Trojanowski MA, Trojanowska M (2021) FLI1 and ERG protein degradation is regulated via Cathepsin B lysosomal pathway in human dermal microvascular endothelial cells. Microcirculation 28:e12660","journal-title":"Microcirculation"},{"key":"4189_CR32","doi-asserted-by":"publisher","unstructured":"Neely V, Manchikalapudi A, Nguyen K, Dalton K, Hu B, Koblinski JE, Faber AC, Deb S, Harada H (2023) Targeting oncogenic mutant p53 and BCL-2 for small cell lung cancer treatment. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms241713082","DOI":"10.3390\/ijms241713082"},{"key":"4189_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13062-023-00431-4","volume":"18","author":"NV Pervushin","year":"2023","unstructured":"Pervushin NV, Kopeina GS, Zhivotovsky B (2023) Bcl-B: an \u201cunknown\u201d protein of the Bcl-2 family. Biol Direct 18:69","journal-title":"Biol Direct"},{"key":"4189_CR34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/15548627.2022.2045534","volume":"18","author":"S Prieto Huarcaya","year":"2022","unstructured":"Prieto Huarcaya S, Drobny A, Marques ARA, Di Spiezio A, Dobert JP, Balta D, Werner C, Rizo T, Gallwitz L, Bub S, Stojkovska I, Belur NR, Fogh J, Mazzulli JR, Xiang W, Fulzele A, Dejung M, Sauer M, Winner B, Rose-John S, Arnold P, Saftig P, Zunke F (2022) Recombinant pro-CTSD (cathepsin D) enhances SNCA\/\u03b1-Synuclein degradation in \u03b1-Synucleinopathy models. Autophagy 18:1127\u20131151","journal-title":"Autophagy"},{"key":"4189_CR35","doi-asserted-by":"publisher","first-page":"828","DOI":"10.20517\/cdr.2023.97","volume":"6","author":"A Reyes","year":"2023","unstructured":"Reyes A, Siddiqi T (2023) Targeting BCL2 pathways in CLL: a story of resistance and ingenuity. Cancer Drug Resist 6:828\u2013837","journal-title":"Cancer Drug Resist"},{"key":"4189_CR36","doi-asserted-by":"publisher","unstructured":"Shin J, Park JW, Kim SY, Lee JH, Choi WS, Kim HS (2024) Strategies for overcoming immune evasion in bladder cancer. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/ijms25063105","DOI":"10.3390\/ijms25063105"},{"key":"4189_CR37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0022-2836(02)00780-5","volume":"322","author":"JR Somoza","year":"2002","unstructured":"Somoza JR, Palmer JT, Ho JD (2002) The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators. J Mol Biol 322:559\u2013568","journal-title":"J Mol Biol"},{"key":"4189_CR38","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12890-021-01796-w","volume":"21","author":"L Song","year":"2021","unstructured":"Song L, Wang X, Cheng W, Wu Y, Liu M, Liu R, Zhang S, Xia H, Liu H, Tai X, Zhao H, Li X, Ji F (2021) Expression signature, prognosis value and immune characteristics of cathepsin F in non-small cell lung cancer identified by bioinformatics assessment. BMC Pulm Med 21:420","journal-title":"BMC Pulm Med"},{"key":"4189_CR39","doi-asserted-by":"publisher","unstructured":"Soond SM, Savvateeva LV, Makarov VA, Gorokhovets NV, Townsend PA, Zamyatnin AA, Jr (2020) Making connections: p53 and the cathepsin proteases as co-regulators of cancer and apoptosis. Cancers (Basel) 12. https:\/\/doi.org\/10.3390\/cancers12113476","DOI":"10.3390\/cancers12113476"},{"key":"4189_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1471-2407-5-68","volume":"5","author":"G Vazquez-Ortiz","year":"2005","unstructured":"Vazquez-Ortiz G, Pina-Sanchez P, Vazquez K, Duenas A, Taja L, Mendoza P, Garcia JA, Salcedo M (2005) Overexpression of cathepsin F, matrix metalloproteinases 11 and 12 in cervical cancer. BMC Cancer 5:68","journal-title":"BMC Cancer"},{"key":"4189_CR41","doi-asserted-by":"crossref","unstructured":"Vidak E, Javor\u0161ek U, Vizovi\u0161ek M, Turk B (2019) Cysteine cathepsins and their extracellular roles: shaping the microenvironment. Cells 8:264","DOI":"10.3390\/cells8030264"},{"key":"4189_CR42","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.amjms.2022.03.017","volume":"364","author":"Y Wang","year":"2022","unstructured":"Wang Y, Mei J, Zhang Y, He X, Zheng X, Tan J, Jia Q, Li N, Li D, Wang Y, Meng Z (2022) Cathepsin F genetic mutation is associated with familial papillary thyroid cancer. Am J Med Sci 364:414\u2013424","journal-title":"Am J Med Sci"},{"key":"4189_CR43","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/s41416-022-01744-3","volume":"126","author":"S Wei","year":"2022","unstructured":"Wei S, Liu W, Xu M, Qin H, Liu C, Zhang R, Zhou S, Li E, Liu Z, Wang Q (2022) Cathepsin F and Fibulin-1 as novel diagnostic biomarkers for brain metastasis of non-small cell lung cancer. Br J Cancer 126:1795\u20131805","journal-title":"Br J Cancer"},{"key":"4189_CR44","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1158\/2326-6066.CIR-21-0058","volume":"9","author":"Y Xu","year":"2021","unstructured":"Xu Y, Carrascosa LC, Yeung YA, Chu ML, Yang W, Djuretic I, Pappas DC, Zeytounian J, Ge Z, de Ruiter V, Starbeck-Miller GR, Patterson J, Rigas D, Chen SH, Kraynov E, Boor PP, Noordam L, Doukas M, Tsao D, Ijzermans JN, Guo J, Gr\u00fcnhagen DJ, Erdmann J, Verheij J, van Royen ME, Doornebosch PG, Feldman R, Park T, Mahmoudi S, Dorywalska M, Ni I, Chin SM, Mistry T, Mosyak L, Lin L, Ching KA, Lindquist KC, Ji C, Londono LM, Kuang B, Rickert R, Kwekkeboom J, Sprengers D, Huang TH, Chaparro-Riggers J (2021) An engineered IL15 cytokine mutein fused to an anti-PD1 improves intratumoral T-cell function and antitumor immunity. Cancer Immunol Res 9:1141\u20131157","journal-title":"Cancer Immunol Res"},{"key":"4189_CR45","doi-asserted-by":"publisher","first-page":"13556","DOI":"10.1038\/s41598-024-64542-2","volume":"14","author":"X Zhou","year":"2024","unstructured":"Zhou X, Chen H, Huang D, Guan G, Ma X, Cai W, Liao J, Guan T (2024) Reduced expression of cathepsin F predicts poor prognosis in patients with clear cell renal cell carcinoma. Sci Rep 14:13556","journal-title":"Sci Rep"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04189-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:14:43Z","timestamp":1759983283000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04189-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4189"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04189-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shaanxi Provincial People\u2019s Hospital (Approval number: SPPH- 2023011), and all procedures were performed in keeping with the standards set out in the Declaration of Helsinki and Laboratory Guidelines of Research in China and the National Institutes of Health Laboratory Animal Care and Use Guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have provided consent for the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}